Get started
Author

Sneha Subramaniyan

Observed names: Subramaniyan Sneha, Subramaniyan, Sneha
Institution: Alagappa University
Observed institution: Alagappa University
ORCID: 0009-0000-4083-5027
Observed ORCID: 0009-0000-4083-5027
OpenAlex ID: A5112985645
Multilayer precision-based screening of potential inhibitors targeting Mycobacterium tuberculosis acetate kinase using in silico approaches
2023 · Sneha Subramaniyan, Hemavathy Nagarajan, et al. · Computational Biology and Chemistry · 12
Exploring phytochemicals and marine natural products as alternative therapeutic agents targeting phosphotransacetylase (PTA) in Mycobacterium tuberculosis: An underexplored drug target
2025 · Sneha Subramaniyan, Manikandan Jayaraman, et al. · Journal of Molecular Graphics and Modelling · 11
Computational Identification of FDA‐Approved Drugs as Potential BMX Inhibitors: An Integrated Virtual Screening, Pharmacokinetics and Molecular Dynamics Study
2025 · Maharaja Muthuvairam Subbulakshmi, Sneha Subramaniyan, et al. · ChemistrySelect · 4
Unveiling the oncological inhibition of bioactive compounds from Adansonia digitata via in silico analysis by targeting γ-butyrobetaine dioxygenase 1 against triple negative breast cancer
2024 · P. Sangavi, Hemavathy Nagarajan, et al. · Journal of Biomolecular Structure and Dynamics · 4
Targeting hORAI1-Mediated Calcium Influx in Triple-Negative Breast Cancer: A Computational Drug Discovery Approach
2026 · Sangavi Pandi, Hemavathy Nagarajan, et al. · The Journal of Membrane Biology · 3
Integrated subtractive genomics and inhibitor identification of novel FAD-dependent monooxygenase in Nocardia farcinica JJSBBCNF_01
2025 · Shaslinah Nathar, Hemavathy Nagarajan, et al. · Biochemical and Biophysical Research Communications · 3
Harnessing allosteric inhibition: prioritizing LIMK2 inhibitors for targeted cancer therapy through pharmacophore-based virtual screening and essential molecular dynamics
2023 · Raghu Rangaswamy, Nagarajan Hemavathy, et al. · Journal of Biomolecular Structure and Dynamics · 3
PDF
Strategic targeting of AckA in Mycobacterium tuberculosis using peptide inhibitors
2025 · Sneha Subramaniyan, Hemavathy Nagarajan, et al. · Archives of Microbiology · 2
Structural insights of WBmDapE and deciphering of potent anti-filarial inhibitors: a state-of-art computational approach
2025 · Poopandi Saritha, Nagarajan Hemavathy, et al. · Molecular Diversity · 1
PDF
Computational discovery of AKT serine/threonine kinase 1 inhibitors through shape screening for rheumatoid arthritis intervention
2024 · Raghu Rangaswamy, Subramaniyan Sneha, et al. · Molecular Diversity · 1
Innovative Approaches in Drug Discovery: Target Identification, Computational Strategies, and Emerging Trends in ML and AI Integration
2026 · Sneha Subramaniyan, Karthika Alagesan, et al. · BENTHAM SCIENCE PUBLISHERS eBooks
Probing the conserved catalytic mechanism of ThiL protein in pathogenic Leptospira species: An in silico strategy for inhibitor discovery to combat leptospirosis
2026 · Maheswari Narthanareeswaran, Hemavathy Nagarajan, et al. · Computers in Biology and Medicine
Crystal Structure of PH0140: Exogenous Amino Acids Induce Open Octameric Assembly Enables PromoterTTTT Binding for Transcription Regulation
2026 · Richard Mariadasse, Mohammed Ahmad, et al. · Journal of Molecular Biology
Targeting Catalytic Residues of TKTL1: A Multi‐Approach Study With Thiamine Analogs Combining QSAR, Pharmacophore Modeling, DFT, and Molecular Dynamics
2025 · Mariadasse Richard, Sneha Subramaniyan, et al. · ChemistrySelect
Structure-Guided Design of Isoform-Selective LIMK1 Inhibitors: A Peptidomimetic Screening Approach with Molecular Dynamics and Quantum Mechanical Characterization
2025 · Nagarajan Hemavathy, Sneha Subramaniyan, et al. · Journal of Computational Biophysics and Chemistry
Works count: 17
Citation count: 44
H-index: 4
I10-index: 2
Year
Topic
Type